Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.

Crippa, S; Conti, A; Vavassori, V; Ferrari, S; Beretta, S; Rivis, S; Bosotti, R; Scala, S; Pirroni, S; Jofra-Hernandez, R; Santi, L; Basso-Ricci, L; Merelli, I; Genovese, P; Aiuti, A; Naldini, L; Di Micco, R; Bernardo, Me.